The official announcement of which 16 Teams would be competing in the 2012 edition of the Amgen Tour of California was made today.
The Teams are: AG2R La Mondiale, BMC Racing Team, Greenedge Cycling Team, Liquigas-Cannondale, Omega Pharma - Quick Step, Rabobank Cycling Team, Radio Shack Nissan Trek, Team Garmin-Barracuda, Columbia Coldeportes, Project 1t4i, Team Spidertech powered by C10, United Healthcare Pro Cycling Team, Bissell Pro Cycling, Bontrager Livestrong, Team Exergy and Optum Pro Cycling.
The Amgen Tour of California is listed by the UCI as a 2.HC event in the America Tour, as such this means that the event is run under UCI regulations.
Now, look back up at that list of Teams again. Notice anything? Radio Shack Nissan Trek are taking part, as are Bontrager Livestrong - the UCI mandated development squad for Radio Shack.
The UCI cycling regulations specifically ban any development squads from competing in the same event as the UCI ProTeam (excluding single events)
to quote the regulations in their entirety:
2.2.001 - Participation.
Riders belonging to Teams with the same paying agent or main partner may not compete in the same race except in the case of an individual event. Furthermore, no more than one National Team of each Nationality may compete in an event. In addition, the participation of both a UCI ProTeam and the development Team supported by this same UCI ProTeam in accordance with article 2.15.130 is prohibited.
Section 2.15.130 of the regulations dictates that all UCI ProTour Teams must support young riders or grass roots racing. Specifically:
The UCI ProTour Team must carry out a training programme for young riders and / or a programme to support grass roots cycling. The details of these programmes shall be agreed by contract between the UCI ProTour Team and the UCI.
Why is this an issue?
Each Team competes with 8 riders. There are no substitutions, you start with 8 and finish with whoever makes it to the line. However, with both a Pro Team and their Development Squad in the same race, the effective Team size is doubled, giving an obvious (and unfair), advantage to the Team in question - in this case Radio Shack Nissan Trek.
The UCI Cycling Regulations clearly state that this situation is not permitted in events run under their rules, yet Amgen have clearly, publicly broken this rule. Will the UCI do anything about it? Or, like Lance Armstrong making his return to competition at the Tour Down Under while not having complied fully with the anti-doping testing requirements, will another rule be ignored?
If the UCI do nothing to remedy this breach of regulations that every Team has to comply with,surely serious questions have to be raised about their ability to manage the sport fairly and impartialy.